Edesa Biotech logo
Edesa Biotech EDSA
€ 12.24 -7.12%

Quartalsbericht 2025-Q4
hinzugefügt 13.02.2026

report update icon

Edesa Biotech Langfristiger Schuldenstrom 2011-2026 | EDSA

Langfristiger Schuldenstrom Jährlich Edesa Biotech

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
19.9 K 74.7 K 19 K 78.8 K 69.7 K - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
78.8 K 19 K 52.4 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Exelixis Exelixis
EXEL
27.9 M $ 48.43 9.03 % $ 13.2 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
2.13 M $ 2.56 3.96 % $ 71.4 M usaUSA
Galapagos NV Galapagos NV
GLPG
1.73 M $ 28.78 1.36 % $ 2.69 B belgiumBelgium
Genmab A/S Genmab A/S
GMAB
26 M $ 27.93 1.41 % $ 17.2 B danmarkDanmark
Grifols, S.A. Grifols, S.A.
GRFS
117 M $ 8.41 1.69 % $ 6.83 B spainSpain
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
257 K $ 2.47 25.39 % $ 152 M germanyGermany
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
9.51 M $ 76.96 2.27 % $ 12.3 B usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
2.12 M $ 8.3 1.1 % $ 260 M israelIsrael
BioNTech SE BioNTech SE
BNTX
45 M $ 95.07 -0.45 % $ 27.2 B germanyGermany
Kymera Therapeutics Kymera Therapeutics
KYMR
11.9 M $ 86.14 4.15 % $ 7.28 B usaUSA
Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals Incorporated
LGND
1.27 M $ 229.83 -1.06 % $ 4.2 B usaUSA
INmune Bio INmune Bio
INMB
623 K $ 1.52 -1.3 % $ 37.6 M usaUSA
Liquidia Corporation Liquidia Corporation
LQDA
900 K $ 41.84 4.26 % $ 3.6 B usaUSA
Mirum Pharmaceuticals Mirum Pharmaceuticals
MIRM
2.14 M $ 107.42 1.52 % $ 5.39 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.32 -0.13 % $ 3.7 B usaUSA
MannKind Corporation MannKind Corporation
MNKD
2.11 M $ 3.68 28.5 % $ 1.12 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.13 0.55 % $ 651 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.47 -8.44 % $ 5.71 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.86 1.88 % $ 3.04 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Puma Biotechnology Puma Biotechnology
PBYI
1.31 M $ 7.5 2.04 % $ 375 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA